youtube_live
Pendapatan Q3 2026 • dikeluarkan • EPS melebihi +128.03% • Hasil melebihi +7.03%
Lihat hasilchevron_right
1AE:ETR
argenx SE
€784.40
arrow_upward
+0.08%(+0.60) 1H
22 Okt, 5:35:45 PTG GMT+2 · EUR
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk 1AE...
Buka
€777.20
Tinggi
€800.20
Rendah
€755.60
Permodalan Pasaran
51.41B
Purata volum
205.00
Volum
314.00
Nisbah H/P
33.48
tgi 52 mgu
€922.00
rdh 52 mgu
€574.20
EPS
€23.43
Bilangan pekerja
2K
Buka
€777.20
Tinggi
€800.20
Rendah
€755.60
Permodalan Pasaran
51.41B
Purata volum
205.00
Volum
314.00
Nisbah H/P
33.48
tgi 52 mgu
€922.00
rdh 52 mgu
€574.20
EPS
€23.43
Bilangan pekerja
2K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Investing.com
·
1 jam lalu
Jefferies reiterates argenx stock Buy rating after Q3 beat
BigGo Finance
·
3 jam lalu
[argenx SE Q3 2026 Earnings Call] argenx Posts $1.7B in Q3 Sales, Up 54%, as Seronegative MG 'Halo Effect' Surprises Management; Eyes Five U.S. Launches in 2027
Investing.com
·
4 jam lalu
Stifel cuts argenx stock price target on mixed quarter results
Benzinga
·
5 jam lalu
argenx Q3 2026 Earnings Call Transcript
Profil
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
Perihal argenx SE